INHIBITORS OF RENIN - PRESENT AND FUTURE

被引：12
|
作者：
HABER, E [1 ]
机构：
[1] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
来源：
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE | 1983年 / 5卷 / 7-8期
关键词：
D O I：
10.3109/10641968309048851
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1193 / 1205
页数：13
相关论文
共 50 条
  • [21] CIRCULATING AND TISSUE RENIN-ANGIOTENSIN SYSTEM - PRESENT AND FUTURE - DISCUSSION
    BES, A
    CORVOL, P
    DZAU, VJ
    FILLASTRE, JP
    LEKIEFFRE, J
    PASSA, P
    VASMANT, D
    WAEBER, B
    ZANCHETTI, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 : S60 - S65
  • [22] The past, present and future of renin-angiotensin aldosterone system inhibition
    Mentz, Robert J.
    Bakris, George L.
    Waeber, Bernard
    McMurray, John J. V.
    Gheorghiade, Mihai
    Ruilope, Luis M.
    Maggioni, Aldo P.
    Swedberg, Karl
    Pina, Ileana L.
    Fiuzat, Mona
    O'Connor, Christopher M.
    Zannad, Faiez
    Pitt, Bertram
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (05) : 1677 - 1687
  • [23] Topoisomerase II inhibitors in AML: past, present, and future
    Economides, Minas P.
    McCue, Deborah
    Borthakur, Gautam
    Pemmaraju, Naveen
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (13) : 1637 - 1644
  • [24] Matrix metalloproteinase inhibitors: Present achievements and future prospects
    L.J. Denis
    J. Verweij
    Investigational New Drugs, 1997, 15 : 175 - 185
  • [25] Past, Present, and Future of Entry Inhibitors as HIV Microbicides
    Gibson, Richard M.
    Arts, Eric J.
    CURRENT HIV RESEARCH, 2012, 10 (01) : 19 - 26
  • [26] Matrix metalloproteinase inhibitors: Present achievements and future prospects
    Denis, LJ
    Verweij, J
    INVESTIGATIONAL NEW DRUGS, 1997, 15 (03) : 175 - 185
  • [27] Steroid Sulphatase and Its Inhibitors: Past, Present, and Future
    Foster, Paul A.
    MOLECULES, 2021, 26 (10):
  • [28] Pharmacogenetics of aromatase inhibitors: Present understanding and looking to the future
    Connolly R.
    Stearns V.
    Current Breast Cancer Reports, 2010, 2 (3) : 138 - 145
  • [29] Profiles of COX-2 inhibitors: present and future
    Chung, S
    Lim, KM
    Shin, SS
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (01) : 9 - 32
  • [30] PCSK9 inhibitors - past, present and future
    Reiner, Zeljko
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (10) : 1517 - 1521
12345